RayKnowChina Research Map
Shortlist

BeijingPeking Union Medical College / Chinese Academy of Medical Sciences

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

中国医学科学院肿瘤医院

Listed for 3 of the 61 diseases this site covers, from the research papers it led and the trials registered with it as lead sponsor or site.

Research activity in public records, not a rating of care. Whether the hospital can help a particular patient is for the hospital and the treating doctor to say.

No official website checked for this hospital yet.

Getting in touch

Research at Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Choose a disease to see the papers and trials behind it. Each tile shows papers led, 2021–2025, and papers per year.

Only the 61 diseases this site covers. A disease it is not listed for means this hospital did not meet the listing rule for that disease in these records; it does not mean the hospital does not treat it. Which hospitals are listed

  1. Lung cancer肺癌9 papers led
  2. Breast cancer乳腺癌4 papers led
  3. Lymphoma淋巴瘤0 papers led1 open trial led

Not listed for: Nasopharyngeal carcinoma, Oesophageal squamous cell carcinoma, Hepatocellular carcinoma, Stomach cancer, Pancreatic cancer, Glioma, Hepatoblastoma, Retinoblastoma, Chordoma, Osteosarcoma, Gastrointestinal stromal tumour, Neuroblastoma, Ewing sarcoma, Multiple myeloma, B-cell acute lymphoblastic leukaemia, Aplastic anaemia, Haemophagocytic lymphohistiocytosis, Beta thalassaemia, Haemophilia A, Atypical haemolytic uraemic syndrome, Thrombotic thrombocytopenic purpura, Fanconi anaemia, Neuromyelitis optica spectrum disorder, IgG4-related disease, Myasthenia gravis, Moyamoya disease, Wilson disease, Biliary atresia, Coronary heart disease, Congenital heart disease, Scoliosis, Anti-NMDA receptor encephalitis, Takayasu arteritis, Hepatic echinococcosis, Idiopathic pulmonary fibrosis, Lymphangioleiomyomatosis, Amyotrophic lateral sclerosis, Spinal muscular atrophy, Fabry disease, Pompe disease, Duchenne muscular dystrophy, Behçet disease, Alport syndrome, IgA nephropathy, Gaucher disease, Niemann–Pick disease type C, Osteogenesis imperfecta, Primary biliary cholangitis, Primary sclerosing cholangitis, Congenital diaphragmatic hernia, Hirschsprung disease, Inherited epidermolysis bullosa, Hereditary angioedema, Familial adenomatous polyposis, Leber hereditary optic neuropathy, Majeed syndrome, NGLY1 deficiency, ISG15 deficiency.

Cancer

Lung cancer

肺癌

Led 9 of the 23,356 English-language PubMed papers on lung cancer with an author in mainland China, 2021–2025: 0.04%.

Papers led
9
2021–2025
Trials led
1
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 3320232024: 4420242025: 222025

20 hospitals in Beijing for lung cancer251 hospitals in China for lung cancer

No open trial on lung cancer lists this hospital on ClinicalTrials.gov on 18 Nov 2026.

The records behind these numbers
Departments in papersRadiology / nuclear medicineRadiation oncology

Hospital name read automatically from author addresses, not yet checked by hand.

Papers it led9
  1. Heterogeneity of metastatic gastric cancer: solitary non-regional lymph node metastasis and solitary lung metastasis showed better survival outcomes than other metastatic patterns.2025BMC cancerFree full text
  2. CDH3 promotes the progression of lung adenocarcinoma through driving epithelial-mesenchymal transition progress.2025Journal of translational medicineFree full text
  3. The mediating role of medical coping modes between stigma and quality of life in patients undergoing lung cancer surgery: a cross-sectional study.2024BMC cancerFree full text
  4. A 16-year evaluation of opportunistic lung cancer screening with low-dose CT in China: comparative findings between non-smokers and smokers.2024BMC cancerFree full text
  5. Comprehensive analysis of surgical strategies and prognosis for non-small cell lung cancer with pleural metastasis detected intraoperatively.2024BMC cancerFree full text
  6. Nomogram predicting overall and cancer specific prognosis for poorly differentiated lung adenocarcinoma after resection based on SEER cohort analysis.2024Scientific reportsFree full text
  7. The current status and future of ADC therapy for small cell Lung Cancer: a promising approach.2023Journal of translational medicineFree full text
  8. Application of four-dimensional cone beam computed tomography in lung cancer radiotherapy.2023Radiation oncology (London, England)Free full text
  9. H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma.2023Respiratory researchFree full text
All its trials on ClinicalTrials.gov, any status1
  1. Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLCStatus unknownNCT05974007Lead (inferred)Start 2022-01

Run the PubMed searchClinicalTrials.gov

Cancer

Breast cancer

乳腺癌

Led 4 of the 16,974 English-language PubMed papers on breast cancer with an author in mainland China, 2021–2025: 0.02%.

Papers led
4
2021–2025
Trials led
2
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 1120242025: 332025

20 hospitals in Beijing for breast cancer219 hospitals in China for breast cancer

No open trial on breast cancer lists this hospital on ClinicalTrials.gov on 18 Nov 2026.

The records behind these numbers
Departments in papersMedical oncologyPathology / laboratory medicine

Hospital name read automatically from author addresses, not yet checked by hand.

Run the PubMed searchClinicalTrials.gov

Blood disorders

Lymphoma

淋巴瘤

Led no English-language PubMed papers on lymphoma in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
1
any status, ClinicalTrials.gov
Open trials led
1
recruiting or about to
Open trials as a site
0
led by another institution

22 hospitals in Beijing for lymphoma199 hospitals in China for lymphoma

Open trials with this hospital 1

Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 18 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.

  1. Recruiting
    Predictive Value of Tumor Microenvironment PET/CT for Response and Prognosis in Aggressive Lymphoma
    Phase
    N/A
    Started
    2024-07
    Posted
    Registry
    NCT07657494

    Age 18 years to Not stated (registered criteria)

    Led by Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

The records behind these numbers

Hospital name read automatically from author addresses, not yet checked by hand.

All its trials on ClinicalTrials.gov, any status1
  1. Predictive Value of Tumor Microenvironment PET/CT for Response and Prognosis in Aggressive LymphomaRecruitingNCT07657494Lead (inferred)N/AStart 2024-07

Run the PubMed searchClinicalTrials.gov

Getting in touch

Name card to show staff or a driver

中国医学科学院肿瘤医院

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

北京

Large hospitals often have several campuses. Confirm the campus with the hospital before travelling.

Inquiry letter in English and Chinese

Fill in the brackets, then send it through the contact options on the hospital's international office or official website. Nothing typed here leaves this device.

Records hospitals usually ask for

  • A recent summary or letter from the treating doctor
  • Pathology report
  • Scans (CT, MRI, PET) with their reports, and the images if possible
  • Treatments so far, with dates
  • Current medicines

What to do next

Talk with the treating doctorThis page can be shared with the treating doctor to discuss whether this team's work is relevant.
Check the team is still therePapers lag by months and doctors move. Look for the department on the hospital's own website.
Contact the hospital directlyUse the hospital's own contacts. Hospitals never pay us, and each hospital decides which patients it accepts.

Where these numbers come from

Papers

English-language PubMed papers whose first or last author lists this hospital as their first affiliation, 2021–2025. Definitions

Trials

ClinicalTrials.gov records naming this hospital as lead sponsor or site, as of 8 Nov 2026.

Identifiers and other names

ROR
Cancer Hospital of Chinese Academy of Medical Sciences; Ritan Hospital

Suggest a correctionDownload the data